Table 4

Prediction of the in vivo interaction between metoprolol and paroxetine, based on in vitro inhibition constants of paroxetine corrected for futile binding (Ki) and the estimated in vivo hepatocytosolic inhibitor concentrations ([I])

SubstrateKi[I]4-afmPredicted AUC Ratio4-bObserved AUC Ratio4-c
μM μM
Unbound
 (R)-Metoprololα-Hydroxylation0.0450.110.1
O-Demethylation0.0280.110.6
2.210.5  (4.6–21.4)
 (S)-Metoprololα-Hydroxylation0.0440.110.1
O-Demethylation0.0530.110.6
1.96.7  (3.2–14.4)
Total
 (R)-Metoprololα-Hydroxylation0.0452.140.1
O-Demethylation0.0282.140.6
3.210.5  (4.6–21.4)
 (S)-Metoprololα-Hydroxylation0.0442.140.1
O-Demethylation0.0532.140.6
3.26.7  (3.2–14.4)
  • 4-a  Estimated according to eq. 5.

  • 4-b  Calculated according to eq. 6.

  • 4-c  In vivo observed AUC ratio (range) in the presence and in the absence of paroxetine (Hemeryck et al., 2000).